Data rules CIOs won’t leave behind in 2026 guide AI governance and data security strategies at University Hospitals and Corewell Health.
The FDA has qualified AI-Based Histologic Measurement of MASH, or AIM-MASH AI Assist — the first AI drug development tool — ...
A newly developed AI can predict which diseases specific genetic mutations are likely to cause, not just whether they are ...
Should the €6.3 million effort prove successful, it could lead to the adoption of Volition's assay for routine clinical use across France.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback